Cardiology

Clot buster use differs between black and white stroke patients

White stroke patients are much more likely than black patients to be treated in community hospital emergency departments with the clot-busting drug intravenous tissue-plasminogen activator, or tPA, according to preliminary ...

Surgery

Artery-clearing surgery after stroke should be delayed

Treating stroke is a race against time. To prevent brain damage and save lives, physicians have to diagnose and treat strokes as quickly as possible. Now, a new study suggests doctors can reduce risks by delaying a commonly ...

Cardiology

Experimental drug may extend therapeutic window for stroke

A team led by a physician-scientist at the University of Southern California (USC) has created an experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally ...

Cardiology

Study examines safety and efficacy of TPA in mild stroke cases

While the gold standard for stroke care is the use of IV tissue plasminogen activator (tPA, or product name Alteplase) to dissolve clots and mechanical thrombectomy to remove clots in severe to moderate strokes, researchers ...

Cardiology

Clot buster seems to help up to 6 hours after stroke

(HealthDay) -- The largest study of its kind finds that stroke patients benefit from a clot-busting drug even six hours after a stroke, suggesting that the current recommended 4.5-hour limit could be expanded.

page 4 from 6